Janus Henderson Group PLC Syndax Pharmaceuticals Inc Transaction History
Janus Henderson Group PLC
- $182 Billion
- Q2 2024
A detailed history of Janus Henderson Group PLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 39,335 shares of SNDX stock, worth $654,141. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,335
Previous 48,948
19.64%
Holding current value
$654,141
Previous $1.16 Million
30.67%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding SNDX
# of Institutions
206Shares Held
88.1MCall Options Held
498KPut Options Held
76.8K-
Black Rock Inc. New York, NY7.91MShares$131 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA7.34MShares$122 Million0.03% of portfolio
-
Kynam Capital Management, LP Princeton, NJ5.72MShares$95.2 Million9.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$81.3 Million0.0% of portfolio
-
Eversept Partners, LP New York, NY4.11MShares$68.3 Million6.25% of portfolio
About Syndax Pharmaceuticals Inc
- Ticker SNDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,565,200
- Market Cap $941M
- Description
- Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...